Traitements3programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
gammaCore-SThis study is a prospective, multi-centre, randomised, double-blind, sham-controlled investigation designed for comparison of two parallel treatment groups: gammaCore (active nVNS treatment) and a Sham device (control treatment), for the acute treatment of migraine attacks Migraine NA À vérifier Italy À vérifier
gammaCore-S ShamThis study is a prospective, multi-centre, randomised, double-blind, sham-controlled investigation designed for comparison of two parallel treatment groups: gammaCore (active nVNS treatment) and a Sham device (control treatment), for the acute treatment of migraine attacks Migraine NA À vérifier Italy À vérifier
gammaCore-SThis study is a prospective, multi-centre, randomised, double-blind, sham-controlled investigation designed for comparison of two parallel treatment groups: gammaCore (active nVNS treatment) and a Sham device (control treatment), for the acute treatment of migraine attacks Migraine NA À vérifier Italy À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
gammaCore-S Migraine NA NCT02686034 RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.